Welcome to NGC. Skip directly to: Search Box, Navigation, Content.


NGC Search Results

Search Help | Guideline Comparison Help | Guideline Views | Quick Search Tips

Your search criteria:
 

Disease/Condition: "colorectal cancer" OR "colorectal neoplasms" OR "colon cancer" OR "colonic neoplasms"
Guideline Categories: Management, Treatment
Sort Order: Relevance

Your search found 26 related guidelines, which are listed below by relevance. Use the "Limit Search" button to sort by publication date.

To view a guideline summary, click on a title below.

Items 1 to 20      

  Title
Management of colorectal cancer. A national clinical guideline. Scottish Intercollegiate Guidelines Network - National Government Agency [Non-U.S.].  2003 Mar.  47 pages.  NGC:002950

Other Guidelines from this Developer

Surveillance and management of groups at increased risk of colorectal cancer. New Zealand Guidelines Group - Private Nonprofit Organization.  2004 May.  84 pages.  NGC:003655

Other Guidelines from this Developer

Use of raltitrexed (Tomudex) in the management of metastatic colorectal cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.].  1998 May 22 (revised 2005 Feb).  13 pages.  NGC:004434

Other Guidelines from this Developer

Practice parameters for colon cancer. American Society of Colon and Rectal Surgeons - Medical Specialty Society.  2004 Aug.  16 pages.  NGC:003956

Other Guidelines from this Developer

Laparoscopic surgery for colorectal cancer (review). National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].  2006 Aug.  25 pages.  NGC:005409

Other Guidelines from this Developer

Irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].  2005 Aug.  39 pages.  NGC:005418

Other Guidelines from this Developer

Guidelines for the management of colorectal cancer. Association of Coloproctology of Britain and Ireland - Medical Specialty Society.  2001 (revised 2007).  117 pages.  NGC:005904

Other Guidelines from this Developer

The role of oxaliplatin combined with 5-fluorouracil and folinic acid in the first and second-line treatment of advanced colorectal cancer: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.].  2005 (revised 2006 Dec).  33 pages.  NGC:006242

Other Guidelines from this Developer

Oncology evidence-based nutrition practice guideline. American Dietetic Association - Professional Association.  2007 Oct.  Various pagings.  NGC:006621

Other Guidelines from this Developer

Guidelines for laparoscopic resection of curable colon and rectal cancer. American Society of Colon and Rectal Surgeons - Medical Specialty Society
Society of American Gastrointestinal and Endoscopic Surgeons - Medical Specialty Society.  2005 Jul.  12 pages.  NGC:005294

Other Guidelines from this Developer

Follow-up of patients with curatively resected colorectal cancer. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.].  2002 Jun (revised online 2004 Jan).  30 pages.  NGC:003459

Other Guidelines from this Developer

Adjuvant systemic chemotherapy for stage II and III colon cancer following complete resection: guideline recommendations. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.].  1997 Aug 25 (revised 2008 Apr 17).  48 pages.  NGC:006528

Other Guidelines from this Developer

ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. American Society of Clinical Oncology - Medical Specialty Society.  1996 (revised 2006 Nov 20).  15 pages.  NGC:005328

Other Guidelines from this Developer

Capecitabine and oxaliplatin in the adjuvant treatment of stage III (Dukes’ C) colon cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].  2006 Apr.  34 pages.  NGC:005415

Other Guidelines from this Developer

Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan? Evaluation of Genomic Applications in Practice and Prevention (EGAPP) Working Group - Independent Expert Panel.  2009 Jan.  6 pages.  NGC:006963

Other Guidelines from this Developer

The role of Bevacizumab (Avastin®) combined with chemotherapy in the treatment of patients with advanced colorectal cancer: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.].  2005 Dec 12 (revised 2007 Nov 19).  31 pages.  NGC:006314

Other Guidelines from this Developer

Bevacizumab and cetuximab for the treatment of metastatic colorectal cancer. National Institute for Health and Clinical Excellence (NICE) - National Government Agency [Non-U.S.].  2007 Jan.  34 pages.  NGC:005509

Other Guidelines from this Developer

Practice parameters for the surgical treatment of ulcerative colitis. American Society of Colon and Rectal Surgeons - Medical Specialty Society.  1997 (revised 2005 Nov).  13 pages.  NGC:005612

Other Guidelines from this Developer

ASGE guideline: the role of endoscopy in the diagnosis, staging, and management of colorectal cancer. American Society for Gastrointestinal Endoscopy - Medical Specialty Society.  2005 Jan.  7 pages.  NGC:004061

Other Guidelines from this Developer

Laparoscopic surgery for cancer of the colon: a clinical practice guideline. Program in Evidence-based Care - State/Local Government Agency [Non-U.S.].  2005 Sep.  23 pages.  NGC:004715

Other Guidelines from this Developer